Get more replies from employers
Send a job-specific resume in minutes.
Regeneron Pharmaceuticals, Inc (USA) is seeking a Senior Toxicologist to lead nonclinical development programs with guidance from their supervisor, collaborating within cross-functional project teams.
The role requires deep knowledge of GLP regulations and FDA/ICH safety guidelines, with primary responsibility for designing, conducting, interpreting, and reporting regulatory toxicology studies and related pharmacology work in rodent and non-rodent models.
The Senior Toxicologist utilizes their scientific expertise and regulatory experience to lead nonclinical development programs with guidance from their direct supervisor working effectively within cross‑functional project teams. The Senior Toxicologist will demonstrate a thorough understanding of GLP regulations and FDA/EMEA/ICH nonclinical safety guidelines to independently lead the design, conduct, interpretation, and reporting of regulatory toxicology and/or exploratory pharmacology/toxicology studies in rodent and non‑rodent safety models. The Senior Toxicologist will provide primary authorship of all regulatory documentation required for submission packages, demonstrating excellent problem‑solving and communication skills (written and verbal). Experience with multiple therapeutic modalities preferred, including antibody, oligonucleotide, and gene‑therapy products.
Regeneron is an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion or belief (or lack thereof), sex, sexual orientation, gender identity or expression, gender reassignment, marital or civil partnership status, civil status, pregnancy or parental status, age, disability, nationality, citizenship status, ethnic or national origin, membership of the Traveler community, familial status, genetic information, military or veteran status, or any other characteristic protected under applicable law. Where required, we will provide reasonable accommodation to applicants with known disabilities or chronic illnesses during the recruitment process, unless such accommodation would impose undue hardship.